Loftus R - Search Results

1

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. Among authors: loftus r. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

2

Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.

Elbeik T, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2002 May;2(3):275-85. doi: 10.1586/14737159.2.3.275. Expert Rev Mol Diagn. 2002. PMID: 12050866

3

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. McCune JM, et al. Among authors: loftus r. J Clin Invest. 1998 Jun 1;101(11):2301-8. doi: 10.1172/JCI2834. J Clin Invest. 1998. PMID: 9616201 Free PMC article.

4

Cost assessment of the automated VERSANT 440 Molecular System versus the semi-automated System 340 bDNA Analyzer platforms.

Elbeik T, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2007 Nov;7(6):713-22. doi: 10.1586/14737159.7.6.713. Expert Rev Mol Diagn. 2007. PMID: 18020902

5

Global cost modeling analysis of HIV-1 and HCV viral load assays.

Elbeik T, Chen YM, Soutchkov SV, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Pharmacoecon Outcomes Res. 2003 Aug;3(4):383-407. doi: 10.1586/14737167.3.4.383. Expert Rev Pharmacoecon Outcomes Res. 2003. PMID: 19807450

6

HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep/TaqMan test.

Elbeik T, Dalessandro R, Loftus RA, Beringer S. Elbeik T, et al. Among authors: loftus ra. Expert Rev Mol Diagn. 2007 Nov;7(6):723-53. doi: 10.1586/14737159.7.6.723. Expert Rev Mol Diagn. 2007. PMID: 18020903

7

Protease inhibitors: where are they now?

Gold D, Loftus R. Gold D, et al. Among authors: loftus r. GMHC Treat Issues. 1995 Jan;9(1):1-7. GMHC Treat Issues. 1995. PMID: 11367375

8

Immunosuppressive drugs and corticosteroids for HIV infection.

Loftus R. Loftus R. GMHC Treat Issues. 1995 Dec;9(12):5-7, 10-1. GMHC Treat Issues. 1995. PMID: 11362998 Clinical Trial.

9

Importance of Ultraviolet-C (UV-C) Emitter Configuration for the Attenuation of Staphylococcus aureus and Candida auris Pathogens.

Loftus RW, Brindeiro CT, Dexter F, Parra MC, Hwang SM, Wanta B, Szeluga DJ, Hadder BA, Seering MS, Charnin JE. Loftus RW, et al. Cureus. 2024 Oct 16;16(10):e71612. doi: 10.7759/cureus.71612. eCollection 2024 Oct. Cureus. 2024. PMID: 39553089 Free PMC article.

10

Importance of Ultraviolet-C (UV-C) Emitter Configuration for Clostridioides difficile Attenuation.

Brindeiro CT, Dexter F, Parra MC, Walker KM, Hwang SM, Wanta BT, Szeluga DJ, Hadder BA, Seering MS, Charnin JE, Loftus RW. Brindeiro CT, et al. Among authors: loftus rw. Cureus. 2024 Oct 8;16(10):e71096. doi: 10.7759/cureus.71096. eCollection 2024 Oct. Cureus. 2024. PMID: 39512966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters